Concise Review: Human Pluripotent Stem Cells to Produce Cell-Based Cancer Immunotherapy

被引：31
作者：
Zhu, Huang [1 ]
Lai, Yi-Shin [1 ]
Li, Ye [1 ]
Blum, Robert H. [1 ]
Kaufman, Dan S. [1 ]
机构：
[1] Univ Calif San Diego, Dept Med, Div Regenerat Med, San Diego, CA 92103 USA
来源：
STEM CELLS | 2018年 / 36卷 / 02期
关键词：
Cancer immunotherapy; Adoptive cell therapy; Human pluripotent stem cell; T cell; Natural Killer cell; Natural Killer T cell; NATURAL-KILLER-CELLS; CHIMERIC ANTIGEN RECEPTORS; UMBILICAL-CORD BLOOD; TUMOR-INFILTRATING LYMPHOCYTES; ACUTE MYELOID-LEUKEMIA; T-CELLS; HEMATOPOIETIC STEM; NK CELLS; IN-VIVO; ADOPTIVE TRANSFER;
D O I：
10.1002/stem.2754
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
Human pluripotent stem cells (PSCs) provide a promising resource to produce immune cells for adoptive cellular immunotherapy to better treat and potentially cure otherwise lethal cancers. Cytotoxic T cells and natural killer (NK) cells can now be routinely produced from human PSCs. These PSC-derived lymphocytes have phenotype and function similar to primary lymphocytes isolated from peripheral blood. PSC-derived T and NK cells have advantages compared with primary immune cells, as they can be precisely engineered to introduce improved anti-tumor activity and produced in essentially unlimited numbers.
引用
收藏
页码：134 / 145
页数：12
相关论文
共 50 条
  • [41] Ovarian cancer treatment and natural killer cell-based immunotherapy
    Fan, Zhongru
    Han, Dongyu
    Fan, Xin
    Zhao, Lin
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [42] NK Cell-Based Immunotherapy in Cancer Metastasis
    Lorenzo-Herrero, Seila
    Lopez-Soto, Alejandro
    Sordo-Bahamonde, Christian
    Gonzalez-Rodriguez, Ana P.
    Vitale, Massimo
    Gonzalez, Segundo
    [J]. CANCERS, 2019, 11 (01):
  • [43] Dendritic cell-based nanovaccines for cancer immunotherapy
    Paulis, Leonie E.
    Mandal, Subhra
    Kreutz, Martin
    Figdor, Carl G.
    [J]. CURRENT OPINION IN IMMUNOLOGY, 2013, 25 (03) : 389 - 395
  • [44] Interleukin 15 in Cell-Based Cancer Immunotherapy
    Zhou, Yang
    Husman, Tiffany
    Cen, Xinjian
    Tsao, Tasha
    Brown, James
    Bajpai, Aarushi
    Li, Miao
    Zhou, Kuangyi
    Yang, Lili
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (13)
  • [45] Emerging Human Pluripotent Stem Cell-Based Human-Animal Brain Chimeras for Advancing Disease Modeling and Cell Therapy for Neurological Disorders
    Ji, Yanru
    Mclean, Jenna Lillie
    Xu, Ranjie
    [J]. NEUROSCIENCE BULLETIN, 2024, 40 (09) : 1315 - 1332
  • [46] Induced pluripotent stem cell-based mapping of β-globin expression throughout human erythropoietic development
    Vanuytsel, Kim
    Matte, Taylor
    Leung, Amy
    Naing, Zaw Htut
    Morrison, Tasha
    Chui, David H. K.
    Steinberg, Martin H.
    Murphy, George J.
    [J]. BLOOD ADVANCES, 2018, 2 (15) : 1998 - 2011
  • [47] Challenges of NK cell-based immunotherapy in the new era
    Fang, Fang
    Xiao, Weihua
    Tian, Zhigang
    [J]. FRONTIERS OF MEDICINE, 2018, 12 (04) : 440 - 450
  • [48] Commentary on human pluripotent stem cell-based blood–brain barrier models
    Ethan S. Lippmann
    Samira M. Azarin
    Sean P. Palecek
    Eric V. Shusta
    [J]. Fluids and Barriers of the CNS, 17
  • [49] Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy
    Zhou, Yang
    Li, Miao
    Zhou, Kuangyi
    Brown, James
    Tsao, Tasha
    Cen, Xinjian
    Husman, Tiffany
    Bajpai, Aarushi
    Dunn, Zachary Spencer
    Yang, Lili
    [J]. CANCERS, 2022, 14 (09)
  • [50] Pluripotent Stem Cell-Based Therapeutics for Muscular Dystrophies
    Selvaraj, Sridhar
    Kyba, Michael
    Perlingeiro, Rita C. R.
    [J]. TRENDS IN MOLECULAR MEDICINE, 2019, 25 (09) : 803 - 816
12345